Recruiting
Type 1 diabetes mellitus
RecruitingSafety and Pharmacokinetic Dose-Escalation Study of IMC-S118AI and Sodium Chloride in HLA‑A*02:01‑Positive Participants with Type 1 Diabetes
Registered drug
Safety and Pharmacokinetic Dose-Escalation Study of IMC-S118AI and Sodium Chloride in HLA‑A*02:01‑Positive Participants with Type 1 Diabetes
Registered drug
- Disease:Type 1 diabetes mellitus
- Substances:IMC S118AISodium Chloride
Countries:
Austria
Austria- Participants:0–17 years · 18–64 years
- Substances:IMC S118AI